CG
DEAD

Serial Number

79379517

Owner

Nanjing Curegene Technology Co., Ltd.

Filing Date

Jul 7, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CG Trademark

Serial Number: 79379517

CG is a trademark filed by Nanjing Curegene Technology Co., Ltd. on July 7, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Nanjing Curegene Technology Co., Ltd. (2 trademarks)

Floor 1, Building 3,

Entity Type: 99

Trademark Details

Filing Date

July 7, 2023

Registration Date

Not Registered

Goods & Services

Immunostimulants; chemical preparations for medical purposes, namely, for gene therapy purpose; veterinary preparations, namely, antioxidants; diagnostic preparations for veterinary purposes; enzyme preparations for veterinary purposes; amino acid preparations for medical purposes; diagnostic preparations for medical purposes; reagents for use in veterinary genetic testing; vaccine preparations; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; biological tissue cultures for medical purposes; enzyme preparations for medical purposes; cultures of microorganisms for medical or veterinary use

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 14, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 27, 2025 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 24, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 24, 2024 ABN2
REFUSAL PROCESSED BY IB
Apr 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 11, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 11, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 23, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 22, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 19, 2024 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Dec 29, 2023 NREP
APPLICATION FILING RECEIPT MAILED
Oct 21, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 29, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 28, 2023 REPR